Clinical Trials on Acute Agitation in New Zealand

Total 1845 results

Rigshospitalet, Denmark

Completed

Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?

Psychomotor Agitation

Denmark
State University of New York - Upstate Medical...

Completed

Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation

Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor

United States
University of Auckland, New Zealand

Completed

Patient-Initiated and ConTrolled Oral Refeeding (PICTOR) (PICTOR)

Acute Pancreatitis

New Zealand
University of Auckland, New Zealand

Completed

MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA) (MIMOSA)

Acute Pancreatitis

New Zealand
Kures, Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults

Acute Pain

New Zealand
University of Auckland, New Zealand

Withdrawn

Oral Refeeding IntOlerance After Nasogastric Tube Feeding (ORION) (ORION)

Acute Pancreatitis

New Zealand
University of Medicine and Dentistry of New Jersey
Nintendo of North America

Completed

Does Distraction With a Hand Held Video Game Reduce Preoperative and Emergence Anxiety in Children?

Pediatric Emergence Agitation and Pain

United States
Zealand University Hospital
University of Copenhagen; Pharma Nord; Psychiatric Research Unit, Region Zealand...

Completed

The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome (MEDACIS)

Depression | Acute Coronary Syndrome

Denmark
Bionomics Limited

Completed

A Study of BNC210 in Elderly Patients With Agitation

Agitation in the Elderly

Australia
Route 92 Medical, Inc.

Completed

Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMITNZ)

Acute Ischemic Stroke

New Zealand
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
Austin Health

Terminated

Bicarbonate in Cardiac Surgery

Acute Kidney Injury

New Zealand, Australia
Unity Health Toronto
Schering-Plough

Completed

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets

Agitation

United States
Stony Brook University

Completed

Liquid Risperidone in the Treatment of Acute Agitation in Psychiatrically Hospitalized Children

Agitation

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia (TRANQUILITY)

Dementia | Agitation,Psychomotor

United States
State University of New York at Buffalo

Completed

Music Intervention for Agitation Reduction in the Pediatric Intensive Care Unit

Critical Illness

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder (SERENITY II)

Bipolar Disorder | Agitation,Psychomotor | Agitation Associated With Bipolar Disorder

United States
Zealand University Hospital

Completed

Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery (PUMAS)

Endothelial Dysfunction | Acute Cholecystitis

Denmark
National University Heart Centre, Singapore
AstraZeneca

Recruiting

PASSIvation of Vulnerable Plaque With AZD5718 in AcuTe Coronary syndromE (PASSIVATE)

Acute Coronary Syndrome

Australia, New Zealand, Singapore
Brent Forester
Medical University of South Carolina; Mayo Clinic; Emory University; The Zucker... and other collaborators

Recruiting

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) (ECT-AD)

Alzheimer Dementia | Agitation,Psychomotor

United States
National Cancer Institute (NCI)

Completed

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditions

United States, Canada, New Zealand
Axsome Therapeutics, Inc.

Enrolling by invitation

A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation

Alzheimer Disease | Agitation in Patients With Dementia of the Alzheimer's Type | Agitation, Psychomotor

United States, Canada
St. Luke's-Roosevelt Hospital Center

Completed

Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children (DexPeds)

Anesthesia | Agitation | Pediatrics

United States
Axsome Therapeutics, Inc.

Completed

Assessing Clinical Outcomes in Alzheimer's Disease Agitation (ACCORD)

Alzheimer Disease | Agitation in Patients With Dementia of the Alzheimer's Type | Agitation,Psychomotor

United States, Canada
BioXcel Therapeutics Inc
Cognitive Research Corporation

Terminated

An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia

Dementia | Agitation

United States
Axsome Therapeutics, Inc.

Completed

Addressing Dementia Via Agitation-Centered Evaluation (ADVANCE)

Alzheimer Disease | Agitation in Patients With Dementia of the Alzheimer's Type | Agitation,Psychomotor

United States, Australia
Intra-Cellular Therapies, Inc.

Terminated

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

Agitation in Dementia, Including Alzheimer's Disease

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Terminated

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Dementia | Agitation

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

Schizophrenia | Agitation

United States
University of Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; Region Capital Denmark; Bevica Fonden; Danish... and other collaborators

Completed

Electrical Stimulation of the Paretic Upper Limb in the Early Stroke Phase

Stroke, Acute

Denmark
Autotune Me LLC
University of Pennsylvania; National Institute on Aging (NIA)

Recruiting

A Music-Based Mobile App for People Living With ADRD

Dementia | Depressive Symptoms | Agitation

United States
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Unity Health Toronto
Roche Pharma AG

Completed

Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department

Dyspnea | Acute Heart Failure | Shortness of Breath

Canada, United States, New Zealand
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)

Dementia | Agitation

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Treatment of Behavioral Symptoms in Alzheimer's Disease

Psychosis | Alzheimer's Disease | Agitation

United States
Axsome Therapeutics, Inc.

Recruiting

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation (ADVANCE-2)

Alzheimer Disease | Agitation | Agitation in Patients With Dementia of the Alzheimer's Type

United States, Puerto Rico
Antisoma Research

Terminated

A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Taiwan, Australia, New Zealand
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Nervous System Diseases | Mental Disorder | Alzheimer's Type | Agitation Associated With Alzheimer's Disease

United States, Germany, France, Bulgaria, Spain, Slovenia, Croatia, Serbia, Russian Federation, Ukraine, Canada, United Kingdom
Yale University
National Institute of Mental Health (NIMH)

Not yet recruiting

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

Psychomotor Agitation | Behavioral Disorder

United States
Rochester General Hospital

Withdrawn

Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium

Delirium | Agitation

United States
ACADIA Pharmaceuticals Inc.

Terminated

Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE)

Agitation and Aggression in Alzheimer's Disease

United States, France, Spain, Chile, United Kingdom
ACADIA Pharmaceuticals Inc.

Completed

A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease

Agitation and Aggression in Alzheimer's Disease

United States, Spain, Chile, France, United Kingdom
JHSPH Center for Clinical Trials
National Institute of Mental Health (NIMH); National Institute on Aging (NIA)

Completed

Citalopram for Agitation in Alzheimer's Disease (CitAD)

Alzheimer's Disease | Agitation

United States, Canada
Alere San Diego

Completed

Heart Failure (HF) Outpatient Monitoring Evaluation (HOME) Study (HOME)

Heart Failure | Acute Decompensated Heart Failure | Systolic Heart Failure

United Kingdom, Australia, New Zealand, Sweden, Ireland, Netherlands
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type

Agitation in Participants With Dementia of the Alzheimer's Type

United States, Canada
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

France, United States, Bulgaria, Slovenia, United Kingdom, Russian Federation, Ukraine, Finland, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Agitation in Patients With Dementia of the Alzheimer's Type

United States, Estonia, Germany, Poland, Portugal, Puerto Rico
JHSPH Center for Clinical Trials
National Institute on Aging (NIA)

Active, not recruiting

Escitalopram for Agitation in Alzheimer's Disease (S-CitAD)

Dementia

United States, Canada
Otsuka Australia Pharmaceutical Pty Ltd

Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia (PREFER-HMA)

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient Preference

New Zealand, Australia
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

Spain, United States, Germany, Croatia, Serbia, Russian Federation, Ukraine

Clinical Trials on Acute Agitation in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations